top of page

Myrobalan's CEO describes the challenge of aiming to develop restorative therapies in CNS through remyelination and anti-neuroinflammation

Jing Wang explains how her company is focused on restoring CNS conditions such as MS and ALS, and talks targets.





Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page